Literature DB >> 24389437

Prognostic impact of tumor size eliminating the ground glass opacity component: modified clinical T descriptors of the tumor, node, metastasis classification of lung cancer.

Shota Nakamura1, Takayuki Fukui, Tetsuo Taniguchi, Noriyasu Usami, Koji Kawaguchi, Futoshi Ishiguro, Akihiro Hirakawa, Kohei Yokoi.   

Abstract

INTRODUCTION: The presence of ground glass opacity (GGO) on high-resolution computed tomography (HRCT) is well known to be pathologically closely associated with adenocarcinoma in situ. Recently, measuring the tumor diameter including areas of GGO on HRCT has been reported to possibly overestimate the T status. The purpose of this study was to evaluate the significance of the tumor size measured eliminating the area of GGO on HRCT as a prognostic factor and to propose a refined TNM classification based on modified T descriptors.
METHODS: Four hundred seventy-five patients with clinical T1a-T2bN0M0 non-small-cell lung cancer underwent surgical resection. All tumors were reclassified based on the diameter measured eliminating the GGO area on HRCT according to the seventh TNM classification of lung cancer. We defined this new classification as modified T descriptors categorizing into five groups: mTis, mT1a, mT1b, mT2a, and mT2b. The overall survival rates of the patients in the current and modified staging groups were evaluated.
RESULTS: The 5-year survival rates were 88% and 82% in the patients with T1a and T1b tumors and 90% and 75% in the patients with mT1a and mT1b tumors, respectively. The differences in the survival rate of the patients classified by using mT1a and the other modified T descriptors were more clearly separated statistically than those of the patients classified by using the current T1a and other T descriptors.
CONCLUSION: The modified T descriptors of the tumor size measured eliminating the GGO component on HRCT more clearly classified the prognoses of patients with early lung cancer than did the current T classification.

Entities:  

Mesh:

Year:  2013        PMID: 24389437     DOI: 10.1097/JTO.0000000000000020

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  9 in total

1.  The Role of Extent of Surgical Resection and Lymph Node Assessment for Clinical Stage I Pulmonary Lepidic Adenocarcinoma: An Analysis of 1991 Patients.

Authors:  Morgan L Cox; Chi-Fu Jeffrey Yang; Paul J Speicher; Kevin L Anderson; Zachary W Fitch; Lin Gu; Robert Patrick Davis; Xiaofei Wang; Thomas A D'Amico; Matthew G Hartwig; David H Harpole; Mark F Berry
Journal:  J Thorac Oncol       Date:  2017-01-08       Impact factor: 15.609

2.  Verification of T descriptor with consolidation size for sub-centimeter non-small cell lung cancer.

Authors:  Masaki Goto; Koji Kawaguchi; Takayuki Fukui; Shota Nakamura; Shuhei Hakiri; Naoki Ozeki; Shunsuke Mori; Kumiko Hashimoto; Toshinari Ito; Kohei Yokoi
Journal:  Surg Today       Date:  2019-05-22       Impact factor: 2.549

Review 3.  Controversies on lung cancers manifesting as part-solid nodules.

Authors:  Rowena Yip; Kunwei Li; Li Liu; Dongming Xu; Kathleen Tam; David F Yankelevitz; Emanuela Taioli; Betsy Becker; Claudia I Henschke
Journal:  Eur Radiol       Date:  2017-08-23       Impact factor: 5.315

4.  Comparisons of the clinicopathological features and survival outcomes between lung cancer patients with adenocarcinoma and squamous cell carcinoma.

Authors:  Takayuki Fukui; Tetsuo Taniguchi; Koji Kawaguchi; Koichi Fukumoto; Shota Nakamura; Yukinori Sakao; Kohei Yokoi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2015-05-30

5.  The Outcomes of a Limited Resection for Non-Small Cell Lung Cancer Based on Differences in Pathology.

Authors:  Motoki Yano; Junji Yoshida; Terumoto Koike; Kotaro Kameyama; Akira Shimamoto; Wataru Nishio; Kentaro Yoshimoto; Tomoki Utsumi; Takayuki Shiina; Atsushi Watanabe; Yasushi Yamato; Takehiro Watanabe; Yusuke Takahashi; Makoto Sonobe; Hiroaki Kuroda; Makoto Oda; Masayoshi Inoue; Masayuki Tanahashi; Hirofumi Adachi; Masao Saito; Masataro Hayashi; Hajime Otsuka; Teruaki Mizobuchi; Yasumitsu Moriya; Mamoru Takahashi; Shigeto Nishikawa; Yuki Matsumura; Satoru Moriyama; Yoshitaka Fujii
Journal:  World J Surg       Date:  2016-11       Impact factor: 3.352

6.  Prognostic impact of nomogram based on whole tumour size, tumour disappearance ratio on CT and SUVmax on PET in lung adenocarcinoma.

Authors:  So Hee Song; Joong Hyun Ahn; Ho Yun Lee; Geewon Lee; Joon Young Choi; Jun Kang; Eun Young Kim; Joungho Han; O Jung Kwon; Kyung Soo Lee; Hong Kwan Kim; Yong Soo Choi; Jhingook Kim; Young Mog Shim
Journal:  Eur Radiol       Date:  2015-10-11       Impact factor: 5.315

7.  Air bronchogram in pleomorphic carcinoma of the lung is associated with favorable prognosis.

Authors:  Hideko Onoda; Tokuhiro Kimura; Hiroyuki Tao; Kazunori Okabe; Tsuneo Matsumoto; Eiji Ikeda
Journal:  Thorac Cancer       Date:  2018-04-06       Impact factor: 3.500

8.  Postoperative recurrence of clinical early-stage non-small cell lung cancers: a comparison between solid and subsolid nodules.

Authors:  Shingo Iwano; Hiroyasu Umakoshi; Shinichiro Kamiya; Kohei Yokoi; Koji Kawaguchi; Takayuki Fukui; Shinji Naganawa
Journal:  Cancer Imaging       Date:  2019-06-07       Impact factor: 3.909

9.  Survival Prediction Model Using Clinico-Pathologic Characteristics for Nonsmall Cell Lung Cancer Patients After Curative Resection.

Authors:  Ching-Yang Wu; Jui-Ying Fu; Ching-Feng Wu; Ming-Ju Hsieh; Yun-Hen Liu; Yi-Cheng Wu; Cheng-Ta Yang; Ying-Huang Tsai
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.